Research Progress on Cognitive Dysfunction in Moyamoya Disease

Abstract

Abstract:

Moyamoya disease is a progressive cerebrovascular disease with unknown etiology accompanied by cognitive impairment. Clinical features in the pediatric and adult populations including dysfunction on intelligence, memory, executive function and quality of life, together with outcome of this disease are expounded in this article. Early detection and intervention with surgical revascularization are considered benefit to reduce the cognitive impairment and prevent the progression of cognitive impairment.

Key words: Moyamoya disease; Cognitive function; Cerebral revascularization

摘要：

烟雾病是一种病因不明的进展性脑血管病，认知功能损害是其常见伴随症状，本文分别从烟雾病对儿童及成人智力、记忆力、执行功能损伤的临床特征、对生活质量的影响以及转归进行阐述。目前认为早期发现、早期进行外科干预治疗对减轻烟雾病的认知功能损害、预防认知功能损害的进展十分有效。

关键词: 烟雾病; 认知功能; 脑血管重建

REN Bing*, LI De-Sheng, YANG Wei-Zhong, ZHAO Feng, HAN Cong, ZHANG Zheng-Shang, DUAN Lian.. Research Progress on Cognitive Dysfunction in Moyamoya Disease[J]. Chinese Journal of Stroke, 2013, 8(12): 998-1002.

任斌1，2，李德生1，杨伟中1，赵峰1，韩聪1，张正善1，段炼1. 烟雾病认知功能损害的研究进展[J]. 中国卒中杂志, 2013, 8(12): 998-1002.

References

1 Takahashi JC, Miyamoto S. Moyamoya disease:recent progress and outlook[J]. Neurol Med Chir (Tokyo), 2010, 50:824-832.

2 Weinberg DG, Rahme RJ, Aoun SG, et al. Moyamoya disease:Functional and neurocognitive outcomes in the pediatric and adult populations[J]. Neurosurg Focus, 2011, 30:E21.

3 Ishii R, Takeuchi S, Ibayashi K, et al. Intelligence in children with moyamoya disease:evaluation after surgical treatments with special reference to changes in cerebral blood flow[J]. Stroke, 1984, 15:873-877.

4 Hogan AM, Kirkham FJ, Isaacs EB, et al. Intellectual decline in children with moyamoya and sickle cell anaemia[J]. Dev Med Child Neurol, 2005, 47:824-829.

5 Matsushima Y, Aoyagi M, Nariai T, et al. Long-term intelligence outcome of post-encephalo-duro-arteriosynangiosis childhood Moyamoya patients[J]. Clin Neurol Neurosurg, 1997, 99:S147-S150.

6 Matsushima Y, Aoyagi M, Koumo Y, et al. Effects of encephalo-duro-arterio- synangiosis on childhood moyamoya patients-swift disappearance of ischemic attacks and maintenance of mental capacity[J]. Neurol Med Chir (Tokyo), 1991, 31:708-714.

7 Kuroda S, Houkin K, Ishikawa T, et al. Determinants of intellectual outcome after surgical revascularization in pediat r ic moyamoya disease:a multivar iate analysis[J]. Childs Nerv Syst, 2004, 20:302-308.

8 Imaizumi C, Imaizumi T, Osawa M, et al. Serial intelligence test scores in pediatric moyamoya disease[J]. Neuropediatrics, 1999, 30:294-299.

9 Ezura M, Yoshimoto T, Fujiwara S, et al. Clinical and angiographic follow-up of childhood onset moyamoya disease[J]. Childs Nerv Syst, 1995, 11:591-594.

10 Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis;Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J].Neurol Med Chir (Tokyo), 2012, 52:245-266.

11 Lee JY, Phi JH, Wang KC, et al. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention[J]. Cerebrovasc Dis,2011, 31:230-237.

12 Williams TS, Westmacott R, Dlamini N, et al.Intellectual ability and executive function in pediatric moyamoya vasculopathy[J]. Dev Med Child Neurol,2012, 54:30-37.

13 B o w e n M , M a r k s M P , S t e i n b e r g G K .Neuropsychological recover y f rom childhood moyamoya disease[J]. Brain Dev, 1998, 20:119-123.

14 Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical ar ticle[J]. J Neurosurg, 2009,111:927-935.

15 Patel MD, McKevit t C, Lawrence E. Clinical determinants of long-term quality of life after stroke[J]. Age Ageing, 2007, 36:316-322.

16 Su SH, Hai J, Zhang L, et al. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization[J].Eur J Neurol, 2013, 20:1081-1087.

17 Calviere L, Catalaa I, Marlats F, et al. Correlation be twe en cog n it ive impa i rment a nd c e r ebr a l hemodynamic disturbances on perfusion magnetic r e sona nc e imag i ng i n Eu rope a n a dult s wit h moyamoya disease[J]. J Neurosurg, 2010, 113:753-759.

18 Festa JR, Schwmz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease[J]. J Neurol,2010, 257:806-815.

19 Karzmark P, Zeifert PD, Tan S, et al. Effect of moyamoya disease on neuropsychological functioning in adults[J]. Neurosurgery, 2008, 62:1048-1052.

20 Karzmark P, Zeifert PD, Bell-Stephens TE, et al.Neurocognitive impairment in adults with moyamoya disease without stroke[J]. Neurosurgery, 2012,70:634-638.

21 J e f f e r s o n AL , Gl o s s e r G, De t r e JA, e t a l .Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome[J]. AJNR Am J Neuroradiol, 2006, 27:98-100.

22 Calviere L, Ssi Yan Kai G, Catalaa I, et al. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter[J]. J Neurol Neurosurg Psychiatry, 201283:591-593.

23 Nakamizo A, Kik kawa Y, Hiwat ashi A, et al.Executive function and diffusion in frontal white matter of adults with moyamoya disease[EB/OL].(2013-04-22)[2013-08-15], http://www.strokejournal.org/article/S1052-3057(13)00104-3/abstract.

24 Mogensen MA, Karzmark P, Zeifer t PD, et al.Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease[J]. AJNR Am J Neuroradiol,2012, 33:721-725.

25 Choi JU, Kim DS, Kim EY, et al. Natural history of moyamoya disease:comparison of activity of daily living in surgery and non surgery groups[J]. Clin Neurol Neurosurg, 1997, 99(Suppl 2):S11-S18.

26 Hou kin K, Kuroda S, Nakayama N. Cerebr al revascularization for moyamoya disease in children[J]. Neurosurg Clin N Am, 2001, 12:575-584.

27 Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis[J]. J Neurosurg, 2004, 100:142-149.

28 Ikezaki K, Matsushima T, Kuwabara Y, et al. Cerebral circulation and oxygen metabolism in childhood Moyamoya disease:a perioperative positron emission tomography study[J]. J Neurosurg, 1994, 81:843-850.

29 Touho H, Karasawa J, Ohnishi H, et al. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease[J].Stroke, 1996, 27:282-289.

30 Hsu YH, Kuo MF, Hu a MS, e t a l. Sele c t ive neuropsychological impairments and related clinical factors in children with moyamoya disease of the transient ischemic attack type[J]. Childs Nerv Syst,2013 Sep 5. [Epub ahead of print].

31 Calviere L, Catalaa I, Marlats F, et al. Improvement in cognitive function and cerebral perfusion after bur hole surgery in an adult with moyamoya disease. Case report[J]. J Neurosurg, 2011, 115:347-349.

32 雷宇, 倪伟, 江汉强, 等. 烟雾病与认知损害[J]. 国际脑血管病杂志, 2013, 21:69-73.

33 段炼. 烟雾病[J]. 中国卒中杂志, 2013, 8:557.

[1]	HAN Cong. Challenges in Basic and Clinical Research of Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 735-739.
[2]	DU Haibin, SUN Jian, LIU Wei, ZHANG Dong. A Study on the Correlation between ASPECTS-Based CT Perfusion and DSA Collateral Compensation in Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 755-761.
[3]	CHEN Fangzhou, LONG Tinghan, CHEN Junda, WEN Yunyu, CHEN Siyuan, ZHANG Guozhong, LI Mingzhou, ZHANG Shichao, KANG Huibin, FENG Wenfeng, QI Songtao, WANG Gang. Comparison of Different Temporary Occlusion Strategies for Recipient Arteries in the Application of Superficial Temporal Artery-Middle Cerebral Artery Bypass for Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 762-768.
[4]	YAO Yang, FU Kaikai, ZHU Junrong, ZHAO Ming, CHEN Lei, HAN Yi, LI Qiang, ZHANG Ping. Long-Term Study on Cognitive Function in Adult Patients with Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 769-776.
[5]	ZHANG Houdi, WANG Minjie, ZHANG Qian, SHEN Xuxuan, FU Heguan, HAN Cong. Analysis of Factors Influencing Subjective Sleep Quality in Patients with Chronic Cerebral Ischemia Represented by Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 777-784.
[6]	LIU Yang, YANG Junhua, WU Jun, WANG Shuo. Bioinformatics Analysis of Blood Vessel Samples to Identify Potentially Key Genes Associated with Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(4): 431-439.
[7]	FU Chunling, SONG Biying, YANG Dahui. Relationship between Visual Impairment and Cognitive Function in Elderly Patients with Post-Stroke Mild Cognitive Impairment [J]. Chinese Journal of Stroke, 2024, 19(2): 167-172.
[8]	REN Xiaojia, LIU Guanjie, HAO Wenqiang. A Case Report on the Treatment of Ischemic Stroke Caused by Moyamoya Disease with Ginaton [J]. Chinese Journal of Stroke, 2023, 18(9): 1060-1064.
[9]	ZENG Huixing, LI Jinbiao, WANG Meng, OUYANG Fubing, YU Lei, YI Ming, GUO Jiayu, NI Ruichen, CUI Liqian, FAN Yuhua. Spatial Statistical Analysis based on Fiber Tracerto Study the Changes of Brain Microstructure in Patients with Cerebral Small Vessel Disease Combined with Obstructive Sleep Apnea [J]. Chinese Journal of Stroke, 2023, 18(05): 503-513.
[10]	LUO Wanxian, HE Yiqing, LI Yingjia. Progress of Intracranial and Extracranial Vascular Parameters Evaluation in Moyamoya Disease [J]. Chinese Journal of Stroke, 2023, 18(04): 490-494.
[11]	LIU Chenglong, ZHANG Qian, ZHAO Jizong. Progress of Pathogenesis of Hyperthyroidism Complicated with Moyamoya Disease [J]. Chinese Journal of Stroke, 2023, 18(03): 353-358.
[12]	MA Junwen, BAI Chengping. The Correlation of Serum Inflammatory Factors and Cerebrovascular Reactivity with Cognitive Impairment in Patients with Transient Ischemic Attack [J]. Chinese Journal of Stroke, 2022, 17(12): 1314-1320.
[13]	ZHOU Tiantian, SU Wenjie, LIAN Songyong, LIN Youcong. Effects of Environmental Enrichment on Cognitive Function in Patients with Vascular Dementia after Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1343-1349.
[14]	GUI Jinmin, XUE Rui, LI Na, LIU Qinglin, ZHAO Donghong. Individualized Management of Blood Pressure and Liquid Control for Moyamoya Patients with Hyperperfusion Syndrome after Extracranial-Intracranial Bypass [J]. Chinese Journal of Stroke, 2022, 17(12): 1350-1354.
[15]	HAN Guangsong, NI Jun. Advances in Clinical Classification of Moyamoya Disease [J]. Chinese Journal of Stroke, 2022, 17(10): 1120-1126.